Position in GRAL
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$11,236,679
+$544,092 QoQ
Shares Held
217,428
+74.0% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $889,098,257 across 25 Diagnostics & Research names. GRAL ranks #18 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,302,097 | $246,877,590 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
418,065 | $205,491,489 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
93,297 | $52,422,651 | |
| 4 | ICLR |
Icon PLC
|
399,290 | $44,185,430 | |
| 5 | WAT |
Waters Corp /De/
|
125,534 | $37,384,025 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
216,774 | $36,968,636 | |
| 7 | A |
Agilent Technologies, Inc.
|
297,746 | $33,937,088 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
21,067 | $26,569,700 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,236,679 | 217,428 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $10,692,587 | 124,928 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $15,931,987 | 269,440 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $10,804,216 | 210,117 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $7,272,131 | 284,735 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,767,563 | 211,068 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $5,899,847 | 428,768 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $985,983 | 64,150 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||